Acromegaly: the effect of somatostatin analogues on tumour volume shrinkage
Journal Title: OncoReview - Year 2016, Vol 6, Issue 4
Abstract
Acromegaly is a rare disease, caused by growth hormone (GH) hypersecretion and secondarily elevated insulin-like growth hormone 1 (IGF-1) level. Nearly all patients with acromegaly suffer from somatotroph pituitary adenoma. The main goal of treatment is to normalise both GH and IGF-1 levels, which reduces symptoms, complications and mortality. Transsphenoidal selective adenomectomy performed by an experienced neurosurgeon is the first-line therapy of choice. Therapy with somatostatin analogues (SSA) is used as a neoadjuvant treatment prior to surgery and in a persistent disease following the surgery.
Authors and Affiliations
Przemysław Witek, Marta Gutowska
Keywords
Related Articles
- EP ID EP186904
- DOI 10.5604/01.3001.0009.5058
- Views 220
- Downloads 0
Retrospective assessment of everolimus treatment in patients suffering from advanced renal cell carcinoma
Objective: Results of second-line everolimus treatment in clear cell renal carcinoma. Material and methods: Clinical data of 32 patients of the Clinic of Systemic and Metastatic Malignancies, Centre of Oncology, Maria...
Administration of liposomal doxorubicin in patients with metastatic breast cancer and significant concomitant cardiovascular conditions
A frequent dilemma faced by an oncologist about to take decision on a chemotherapeutic regime for patients with metastatic breast cancer is how to maintain balance between the expected treatment efficacy and predictable...
Dlaczego refundacja leku sierocego wymaga szczególnego podejścia?
Największym problemem dotyczącym refundacji produktów sierocych jest ich wysoka cena. Decyzje refundacyjne i cenowe w przypadku leków sierocych są szczególnie mocno powiązane. Jeśli dotyczą nowo wprowadzanych na rynek te...
Everolimus in clinical practice. Review of German non-interventional study of everolimus in metastatic renal cell cancer after failure of initial tyrosine kinase inhibitor therapy
Everolimus is a standard for treatment of anti-vascular endothelial growth factor (VEGF)-refractory patients with metastatic renal cell carcinoma (mRCC). A German study documented mRCC patient treated everolimus from 79...
Invasive fungal infection in a child with Ewing’s sarcoma
Invasive fungal infection (IFI) in patients with malignant solid tumours is rare, but it highly increases the risk of cancer recurrence because of prolonged discontinuation of cancer treatment. This paper presents a case...